Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

LARGE antibody (AA 35-142)

This Mouse Monoclonal antibody specifically detects LARGE in WB and FACS. It exhibits reactivity toward Human.
Catalog No. ABIN5541530

Quick Overview for LARGE antibody (AA 35-142) (ABIN5541530)

Target

See all LARGE Antibodies
LARGE (Like-Glycosyltransferase (LARGE))

Reactivity

  • 10
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Human

Host

  • 7
  • 2
  • 1
Mouse

Clonality

  • 9
  • 1
Monoclonal

Conjugate

  • 9
  • 1
This LARGE antibody is un-conjugated

Application

  • 8
  • 3
  • 3
  • 2
  • 2
  • 1
Western Blotting (WB), Flow Cytometry (FACS)

Clone

LARGE-02
  • Binding Specificity

    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 35-142

    Specificity

    This antibody recognizes human LARGE1, a glycosyltransferase localizing mainly to the Golgi apparatus. Crossreactivity with LARGE2 was not determined.

    Purification

    Protein-A affinity chromatography (> 95% pure by SDS-PAGE)

    Immunogen

    Recombinant fragment of human LARGE1 (amino acids 35-142)

    Isotype

    IgG2b
  • Application Notes

    Flow cytometry. Western blot.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    95 % pure by SDS-PAGE) Buffer System: Phosphate buffered saline (PBS) Preservatives: 15 mM sodium azide, approx. pH 7.4

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    Store undiluted at 2-8°C. DO NOT FREEZE! Shelf life: one year from despatch.

    Expiry Date

    12 months
  • Target

    LARGE (Like-Glycosyltransferase (LARGE))

    Alternative Name

    large

    Background

    LARGE1 serves as a glycosyltransferase which participates in glycosylation of the muscle membrane protein alpha-dystroglycan. Mutations of LARGE1 lead to hypoglycosylation of alpha-dystroglycan and cause congenital muscular dystrophy (MDC1D) associated with severe mental retardation. Altered alpha-dystroglycan glycosylation may also play a role in cancer, as hypoglycosylation of the protein and loss of laminin binding have been demonstrated in invasive carcinoma cells.

    UniProt

    O95461
You are here:
Chat with us!